Somatic, de novo mutations affecting pluripotent cells and occurring early in embryogenesis can generate lesions in distinct germ layers (Hall, 1988; Youssoufian & Pyeritz, 2002) . Such events give rise to syndromic mosaic disorders including Schimmelpenning-Feuerstein-Mims syndrome (SFM), Cutaneous Skeletal Hypophosphatemia syndrome, and McCune-Albright syndrome (MAS), wherein a multipotent cell acquires a postzygotic mutation in the Ras subfamily or GNAS, respectively, prior to its replication and differentiation into segments of mutant neural, endocrine, skeletal, and skin tissues (Groesser et al., 2012; Lim et al., 2014; Weinstein et al., 1991) . Consequently, multiple end organs present a constellation of symptoms: SFM features ipsilateral keratinocytic or sebaceous nevi associated with central nervous system disorders including epilepsy, seizures, and mental retardation, as well as ocular, skeletal, cardiovascular, and genitourinary anomalies (Groesser et al., 2012) , while MAS patients exhibit melanotic skin patches, polyostotic fibrous dysplasia of the bones, and endocrinopathies (Robinson, Collins, & Boyce, 2016; Weinstein et al., 1991) . Unless the postzygotic mutation affects gonadal tissues as in germline (mutation present in gametes) or gonosomal (mutation in both soma and gametes) mosaicism, such disorders are not transmitted to subsequent generations (Happle, 2016) . Certain mutations, like the AKT1 variants that cause the Proteus syndrome, only manifest as mosaic disorders, as they are likely constitutionally lethal (Lindhurst et al., 2011) . Patterned distributions of lesional tissue such as unilateral or linear presentations suggest genetic mosaicism (Happle, 2016) . However, exceptions such as the coat-like pattern of giant congenital melanocytic nevi arising most commonly from somatic activating mutation in neuroblastoma RAS viral oncogene homolog (NRAS), exist (Charbel et al., 2014) .
Here, we report a 5-year-old boy (MOS100) who presented at 3 years of age with asymptomatic expansion of the right maxillary alveolar ridge (Figure 1a ). His parents gave informed consent for him to be evaluated under a NIDCR IRB-approved protocol and a Yale Human Investigation committee-approved study protocol. Dental radiographic imaging and computed tomography (CT) revealed a fibroosseous lesion suggestive of fibrous dysplasia (Figure 1b Florescence in situ hybridization using the D7Z1 DNA Probe (chromosome 7α satellite DNA) at 7p11.1-q11.1 and homebrew probes RP11-767F15 and RP11-60F17 did not identify BRAF duplication at 7q34 in the brain lesion (Tian et al., 2011) and Sanger sequencing did not identify hotspot mutations in BRAF (V600) and GNAS (R201) mutation in the brain and maxillary lesions (data not shown).
Paired whole exome sequencing was performed using genomic DNA isolated from blood and biopsy of the maxillary lesion (Supporting Table 1 ). Suspecting that the subject's astrocytoma resulted from widespread ACTB mosaicism, we performed targeted sequencing of ACTB in brain biopsy DNA. In so doing, we found the identical c.439C>T, p.147R>C ACTB mutation (Figure 2d ), confirming multilineage ACTB mosaicism affecting the mesoderm (maxilla) and ectoderm (astrocytes) (Figure 2d ).
Beta-actin is one of six isoforms of the highly conserved, ubiquitous "housekeeping" actin, a cytoskeletal protein involved in cell motility, adhesion, and embryonic development (Bunnell, Burbach, Shimizu, & Ervasti, 2011 Donato et al., 2014; Riviere et al., 2012) , an autosomal dominant developmental disorder that features characteristic facies with hypertelorism, ptosis, broad nasal bridge, and pointed chin, along with mental disability and structural brain abnormalities due presumably to impaired neuronal migration (Verloes, Drunat, Pilz, & Di Donato, 2015) . Functional analyses of BWCFF ACTB mutations found altered cell adhesion and polymer instability (Johnston et al., 2013) . Other germline ACTB mutations including p.183R>W cause juvenile-onset dystonia with hearing loss and developmental delay (Conboy et al., 2017) , and this mutation led to alter depolymerization dynamics leading to a morphologically abnormal actin cytoskeleton (Procaccio et al., 2006) .
Notably, the same postzygotic p.147R>C mutation in ACTB as in our subject was recently identified in a majority (14 of 23 examined, 61%) of Becker's nevi (BN) and Becker's nevus syndrome (BNS) subjects, along with a p.147R>S mutation. BN are common benign hamartomas affecting approximately 1 in 200 individuals, with syndromic cases having variable symptoms of cardiomyopathy, developmental delay, and unilateral breast hypoplasia (Cai et al., 2017) . The mutation is localized to the pilar muscle of hair follicles, and was not shown to affect cytoskeletal actin organization or MAPK signaling. In mutation-expressing myoblasts treated with smoothened agonist, however, increased Gli1 expression was found, suggesting that the ACTB p.147R>C mutation in tissues leads to increased Hedgehog (Hh) signaling (Cai et al., 2017) . In our case of fibroosseous dysplasia with pilocytic astrocytoma, the mechanism by which the p.147R>C mutation gives rise to the neoplasms is unclear, though
Gli-dependent aberrant activation of the Hh pathway is a feature of multiple solid tumors and affects tooth development (Hanna & Shevde, 2016; Hardcastle, Mo, Hui, & Sharpe, 1998) . Moreover, the Hh pathway has been shown to regulate the growth of gliomas, and higher levels of GLI1 as well as PTCH, a transcriptional target of the Hh pathway, was demonstrated in pilocytic astrocytomas (Rush, Abel, Valadez, Pearson, & Cooper, 2010) . Finally, ACTB has been demonstrated to play a role in the development of gliomas by facilitating interactions between heat shock proteins and 14-3-3 proteins, which are known to play a role in the pathogenesis of gliomas (Com et al., 2012) . BNS can often feature skeletal defects, though they tend to be structural abnormalities such as hypoplasia of the shoulder girdle and extremities, scoliosis, and pectus excavatum (Happle & Koopman, 1997).
Our findings identify a novel clinical phenotype arising from multilineage ACTB mosaicism and extend the phenotypic spectrum of somatic ACTB mutation diseases to include a unique dental stem cell related facial skeletal disease and pilocytic astrocytoma. The presence of identical somatic mutation in two end organs arising from distinct germ layers confirms early postzygotic mutagenesis affecting a multipotent progenitor. 
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